ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2019.68.27ymj-1233Research ArticleНАУЧНЫЕ ОБЗОРЫ И ЛЕКЦИИSCIENTIFIC REVIEWS AND LECTURESОсобенности течения и современной диагностики хронической сердечной недостаточности на фоне коморбидных ассоциацийFeatures of the course and modern diagnosis of chronic heart failure on the background of comorbid associationsАнкудиновА. С.AnkudinovA. S.

Анкудинов Андрей Сергеевич – к.м.н., доцент

Ankudinov Andrey Sergeevich – PhD, Associate Professor of the Department of Simulation Technologies and Emergency Medical Aid

Irkutsk, 89140107928

andruhin.box@ya.ruКалягинА. Н.KalyaginA. N.

Калягин Алексей Николаевич – д.м.н., проф., зав. кафедрой

Kalyagin Alexey Nikolaevich – doctor of medical sciences, professor, head of the department of propedeutics of internal diseases

Irkutsk, 89643521678

akalagin@yandex.ruИркутский ГМУРоссияIrkutsk State Medical UniversityRussian Federation201929082025049699Copyright © Анкудинов А.С., Калягин А.Н., 20252025Анкудинов А.С., Калягин А.Н.Ankudinov A.S., Kalyagin A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/1233

В обзоре литературы изложена современная информация о течении хронической сердечной недостаточности (ХСН) на фоне коморбидных ассоциаций. Отдельное внимание уделено современным методам диагностики морфофункциональных параметров миокарда, важности иммунологического статуса, вопросам прогноза.

The literature review presents current information on the course of chronic heart failure (CHF) against the background of comorbid associations. Special attention is paid to modern methods of diagnosis of morphofunctional parameters of the myocardium, the importance of immunological status, prognosis.

хроническая сердечная недостаточностькоморбидностьсовременная диагностика ХСНпрогнозchronic heart failurecomorbiditymodern diagnosis of CHFprognosisReferencesАнкудинов А.С. Оценка базовых клинических параметров хронической сердечной недостаточности у женщин, страдающих ревматоидным артритом (предварительные данные) / А.С. Анкудинов, А.Н. Калягин // Забайкальский медицинский вестник. – 2018. – T. 3. – С. 93-98.Ankudinov A.S. Evaluation of the basic clinical parameters of chronic heart failure in women with rheumatoid arthritis (preliminary data) / А.S. Ankudinov, A.N. Kalyagin // Zabaikalsky Medical Vestnik. - 2018. – Vol.3. - p. 93-98.Ефремова Е.В. Проблема коморбидности при хронической сердечной недостаточности / Е.В. Ефремова, А.М. Шутов, Е.О. Бородулина // Ульяновский медико-биологический журнал. ‒ 2015. ‒ №4. ‒ С.46-52.Efremova E.V. The problem of comorbidity in chronic heart failure / E.V. Efremova, A.M. Shutov, E.O. Borodulina // Ulyanovsk medical-biological Journal. - 2015. - 4. - P.46-52.Кардиоренальный синдром при хронической сердечной недостаточности: патогенез, диагностика, прогноз и возможности терапии / Е.А. Медведева, Н.В. Шиляева, Э.Н. Щукин [и др.] // Российский кардиологический журнал. – 2017. – V.22, №1. – С. 136-141.Cardiorenal syndrome in chronic heart failure: pathogenesis, diagnosis, prognosis and treatment options / Y.A. Medvedeva, N.V. Shilyaeva, E.N. Schukin [et al.] // Russian Journal of Cardiology. – 2017. - V.22, №1. - p. 136-141.Кардионкология: современные аспекты профилактики антрациклиновой каридиотоксичнсоти / Ю.А. Васюк, Е.Л. Школьник, В.В. Несветов [и др.] // Кардиология. – 2016. – №12 (56). – С. 72-79. doi: 10.18565/cardio.2016.12.72-79.Cardiac oncology: modern aspects of prophylaxis of anthracycline cariodine toxicity / Yu.A. Vasiuk, E.L. Shkolnik, V.V. Nesvetov [et al.] // Cardiology. - 2016. - №12 (56). - pp.т72-79. doi: 10.18565/cardio.2016.12.72-79.Коморбидная патология в клинической практике.Клинические рекомендации / Р.Г. Оганов, И.Н. Денисов, В.И. Симаненков [и др.] // Кардиоваскулярная терапия и профилактика. ‒ 2017. ‒ №16(6). ‒ C.5-56. doi: 10.15829/1728-8800-2017-6-5-56.Comorbid pathology in clinical practice. Clinical recommendations / R.G. Oganov, I.N. Denisov, V.I. Simanenkov [et al.] // Cardiovascular Therapy and Prevention. - 2017. - №16 (6). - P.5-56. doi: 10.15829 / 1728-8800-2017-6-5-56Коморбидные состояния при различных типах кардиоренального синдрома у больных хронической сердечной недостаточностью / С.Ю. Волкова, К.А. Томашевич, Н.А. Маматулина [и др.] // Медицинская наука и образование Урала. – 2017. – Т.18, № 4. – С.13-17.Comorbid conditions in various types of cardiorenal syndrome in patients with chronic heart failure / S.Yu. Volkova, K.A. Tomashevich, N.A. Mamatulina [et al.] // Medical science and education of the Urals. - 2017. - V.18, №4. - P.13-17.Насонов Е.Л. Ревматические заболевания и мультиморбидность / Е.Л. Насонов, А.В. Гордеев, Е.А. Галушко // Терапевтический архив. ‒ 2015. ‒ №5. ‒ С. 4-9.Nasonov E.L. Rheumatic diseases and multimorbidity / E.L. Nasonov, A.V. Gordeev, E.A. Galushko // Therapeutic archive. - 2015. №5. - p. 4-9.Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать / И.В. Фомин // Российский кардиологический журнал. ‒ 2016. ‒ Т.8. ‒ С.7-13. doi: 10.15829/1560-4071-2016-8-7-13.Fomin I.V. Chronic heart failure in the Russian Federations: what we know today and what we should do / Russian Cardiology Journal // I.V. Fomin. - 2016. - T.8. - C.7-13. doi: 10.15829/1560-4071-2016-8-7-13.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC / P. Ponikowski, A.A. Voors, S.D. Anker [et al.] // European Heart Journal. ‒ 2016. ‒ 37 (27): P.2129–200. doi:10.1093/eurheartj/ehw128.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC / P. Ponikowski, A.A. Voors, S.D. Anker [et al.] // European Heart Journal. ‒ 2016. ‒ 37 (27): P.2129–200. doi:10.1093/eurheartj/ehw128.Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism / A. Huerta, B. Lopez, S. Ravassa [et al.] // J Hypertens. ‒ 2016 ‒ Vol. 34 (1). ‒ P.130-8.Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism / A. Huerta, B. Lopez, S. Ravassa [et al.] // J Hypertens. ‒ 2016 ‒ Vol. 34 (1). ‒ P.130-8.Association of Pentraxin-3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Arch Med Res / X.L. Huang, L. Zhang, Y. Duan [et al.] // J. Arcmed. ‒ 2016. ‒ Vol. 47(3). ‒ P. 223-31. doi: 10.1016/j.arcmed.2016.05.006.Association of Pentraxin-3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Arch Med Res / X.L. Huang, L. Zhang, Y. Duan [et al.] // J. Arcmed. ‒ 2016. ‒ Vol. 47(3). ‒ P. 223-31. doi: 10.1016/j.arcmed.2016.05.006.Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design and preliminary observations from the first 100 000 cases in the acute decompensated heart failure national registry (ADHERE) / K.F. Adams Jr, C.C. Fonarow [et al.] // Am Heart J. ‒ 2005. ‒ 149: P. 209-15.Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design and preliminary observations from the first 100 000 cases in the acute decompensated heart failure national registry (ADHERE) / K.F. Adams Jr, C.C. Fonarow [et al.] // Am Heart J. ‒ 2005. ‒ 149: P. 209-15.Clinical Utility of Three B-Type Natriuretic Peptide Assays for the Initial Diagnostic Assessment of New Slow-Onset Heart Failure / J.C. Kelder, M.J. Cramer, W.M. Verweij // Journal of Cardiac Failure. ‒ 2011. ‒ Vol. 17 (9). ‒ P. 729–34. doi:10.1016/j.cardfail.2011.04.013.Clinical Utility of Three B-Type Natriuretic Peptide Assays for the Initial Diagnostic Assessment of New Slow-Onset Heart Failure / J.C. Kelder, M.J. Cramer, W.M. Verweij // Journal of Cardiac Failure. ‒ 2011. ‒ Vol. 17 (9). ‒ P. 729–34. doi:10.1016/j.cardfail.2011.04.013.Development of congestive heart failure in type 2diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2DIABetes, Hypertension, Cardiovascular Events and Ramipril) study // Diabetes Care. ‒ 2003. ‒ Vol. 26 (3): P.855-860.Development of congestive heart failure in type 2diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2DIABetes, Hypertension, Cardiovascular Events and Ramipril) study // Diabetes Care. ‒ 2003. ‒ Vol. 26 (3): P.855-860.Diabetes in heart failure: prevalence and impact on outcome in the population / A.M. From, C.L. Leibson, F. Bursi // Am. J. Med. – 2006. – 119 (7): P. 591-599.Diabetes in heart failure: prevalence and impact on outcome in the population / A.M. From, C.L. Leibson, F. Bursi // Am. J. Med. – 2006. – 119 (7): P. 591-599.Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity / S.F. Issa, A.F. Christensen, H.M. Lindegaard [et al.] // Scand J Immunol. ‒ 2017. ‒ Vol. 86(6). ‒ P. 471-478. doi: 10.1111/sji.12619.Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity / S.F. Issa, A.F. Christensen, H.M. Lindegaard [et al.] // Scand J Immunol. ‒ 2017. ‒ Vol. 86(6). ‒ P. 471-478. doi: 10.1111/sji.12619.Galectin-3, a potential therapeutic target for rheumatoid arthritis? / Q. Xie, M. Ni, S.C. Wang [et al.] // Scand J Immunol. ‒ 2018. ‒ Vol. 87 (2). ‒ P.108. doi: 10.1111/sji.12631.Galectin-3, a potential therapeutic target for rheumatoid arthritis? / Q. Xie, M. Ni, S.C. Wang [et al.] // Scand J Immunol. ‒ 2018. ‒ Vol. 87 (2). ‒ P.108. doi: 10.1111/sji.12631.Heart failure register: a valuable tool for improving the management of patients with heart falure / A. Jonsson, E. Magnus, A. Urban [et al.] // European Heart Journal. ‒ 2010. ‒ 12. P.25–31.Heart failure register: a valuable tool for improving the management of patients with heart falure / A. Jonsson, E. Magnus, A. Urban [et al.] // European Heart Journal. ‒ 2010. ‒ 12. P.25–31.Mosterd A. Clinical epidemiology of heart failure / A. Mosterd, A.W. Hoes // Heart. ‒ 2007. ‒ 93 (9). P.1137–46. doi: 10.1136/hrt. 2003.025270Mosterd A. Clinical epidemiology of heart failure / A. Mosterd, A.W. Hoes // Heart. ‒ 2007. ‒ 93 (9). P.1137–46. doi: 10.1136/hrt. 2003.025270Nurmohamed M.T. Cardiovascular comor bidity in rheumatic disease / M.T. Nurmohamed, M. Heslinga, G.D. Kitas // Nat Rev Rheumatol. ‒ 2015. ‒11. P.693-704. doi:10.1038/nrrheum.2015.112Nurmohamed M.T. Cardiovascular comor bidity in rheumatic disease / M.T. Nurmohamed, M. Heslinga, G.D. Kitas // Nat Rev Rheumatol. ‒ 2015. ‒11. P.693-704. doi:10.1038/nrrheum.2015.112Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure / S. Suzuki, Y. Takeishi, T. Niizeki [et al.] // Am Heart J. ‒ 2008. ‒ Vol. 155 (1). ‒ P.75–81. Association.Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure / S. Suzuki, Y. Takeishi, T. Niizeki [et al.] // Am Heart J. ‒ 2008. ‒ Vol. 155 (1). ‒ P.75–81. Association.Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular imaging / R.M. Lang, L.P. Badano, V. Mor-Avi [et al.] // Journal American Society Echocardiography. ‒ 2015. ‒ Vol. (28). – P. 1-39. doi:10.1016/j.echo.2014.10.003.Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular imaging / R.M. Lang, L.P. Badano, V. Mor-Avi [et al.] // Journal American Society Echocardiography. ‒ 2015. ‒ Vol. (28). – P. 1-39. doi:10.1016/j.echo.2014.10.003.Relation of plasma levels of adiponectin to left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease / H. Fukuta, N. Ohte, K. Wakami [et al.] // Am J Cardiol. ‒ 2011. ‒ Vol. 15 (108). ‒ P. 1081–5.Relation of plasma levels of adiponectin to left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease / H. Fukuta, N. Ohte, K. Wakami [et al.] // Am J Cardiol. ‒ 2011. ‒ Vol. 15 (108). ‒ P. 1081–5.The Global Economic Burden of Non communicable Diseases / D.E. Bloom, E.T. Cafiero, E. Jané-Llopis [et al.] // Geneva: World Economic Forum. – 2011.The Global Economic Burden of Non communicable Diseases / D.E. Bloom, E.T. Cafiero, E. Jané-Llopis [et al.] // Geneva: World Economic Forum. – 2011.The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction / R. Stahrenberg, F. Edelmann, M. Mende [et al.] // Eur J Heart Fail. ‒ 2010. ‒Vol. 12 (12). ‒ P. 1309–16.The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction / R. Stahrenberg, F. Edelmann, M. Mende [et al.] // Eur J Heart Fail. ‒ 2010. ‒Vol. 12 (12). ‒ P. 1309–16.Utility of biomarkers in the differential diagnosis of heart failure in older people: findings from the Heart Failure in Care Homes (HFinCH) diagnostic accuracy study / J.M. Mason, H.C. Hancock, H. Close [et al.] // PLoS One. ‒ 2013. ‒ Vol. 8 (1). ‒ P. 535-60. RecommendaUtility of biomarkers in the differential diagnosis of heart failure in older people: findings from the Heart Failure in Care Homes (HFinCH) diagnostic accuracy study / J.M. Mason, H.C. Hancock, H. Close [et al.] // PLoS One. ‒ 2013. ‒ Vol. 8 (1). ‒ P. 535-60. Recommenda

The authors declare that there are no conflicts of interest present.